Editorial: What's good for the goose's skeleton is good for the gander's skeleton

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 4, 2006, Pages 1223-1225

  Bilezikian, John P ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; STEROID; TESTOSTERONE; ESTROGEN;

BODY FAT; BONE DENSITY; BONE DEVELOPMENT; BONE GROWTH; BONE MASS; BONE TURNOVER; COHORT ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; EDITORIAL; FRACTURE; FRAGILITY FRACTURE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; IN VITRO STUDY; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; PRIORITY JOURNAL; AGING; ANIMAL; BONE; DRUG EFFECT; FEMALE; GENETICS; MALE; METABOLISM; NOTE; PHYSIOLOGY; SEXUAL DEVELOPMENT;

ANSER SP.;

AGING; ANIMALS; BONE AND BONES; BONE DEVELOPMENT; ESTROGENS; FEMALE; HUMANS; MALE; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 33646040714     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0082     Document Type: Editorial

References (39)

1. Riggs BL, Khosla S, Melton III J 2002 Sex steroids and the construction and conservation of the adult skeleton. J Clin Endocrinol Metab 23:279-2002
2. Gennari L, Nuti R, Bilezikian JP 2004 Aromatase activity and bone homeostasis in men. J Clin Endocrinol Metab 89:5898-5907
3. Pacifici R 1998 Cytokines, estrogen and post-menopausal osteoporosis: the second decade. Endocrinology 139:2659-2661
4. Manolagas SC, Kousteni S, Jilka RL 2002 Sex steroids and bone. Recent Prog Horm Res 57:385-409
5. Smith EP, Boyod J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS 1994 Estrogen resistance caused by a mutation in the estrogen receptor gene in a man. N Engl J Med 331:1056-1061
6. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K 1995 Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689-3698
7. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KH, Simpson ER 1997 Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337:91-95
8. Bilezikian JP, Morishima A, Bell J, Grumbach MM 1998 Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 339:599-603
9. Herrmann BL, Saller B, Janssen OE, Gocke P, Bockisch A, Sperling H, Mann K, Broecker M 2002 Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J Clin Endocrinol Metab 87:5476-5484
10. Boullion R, Bex M, Vanderschueren D, Boonen S 2004 Estrogen are essential for male pubertal periosteal expansion. J Clin Endocrinol Metab 89:6025-6029
11. Slemenda CW, Longcope C, Zhou L, Hui SL, Peacock M, Johnston CC 1997 Sex steroids and bone mass in older men: positive associations with serum estrogens and negative associations with androgens. J Clin Invest 100:1755-1759
12. Szulc P, Munoz B, Claustrat B, Gamero P, Marchand F, Duboeuf F, Delmas PD 2001 Bioavailable estradiol may be an important determinant of osteoporosis in men. The MINOS Study. J Clin Endocrinol Metab 86:192-199
13. Greendale GA, Edelstein S, Barrett-Connor E 1997 Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res 12:1833-1843
14. Amin S, Zhang Y, Sawin CT, Evans SR, Hannan MT, Kiel DP, Wilson PW, Felson DT 2000 Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med 133:951-963
15. Barrett-Connor E, Mueller JE, von Muhlen DG, Laughlin GA, Schneider DL, Sartoris DJ 2000 Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study. J Clin Endocrinol Metab 85:219-223
16. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S 2000 Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106:1553-1560
17. Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS 2003 Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab 88:204-210
18. Taxel P, Kennedy DG, Fall PM, Willard AK, Clive JM, Raisz LG 2001 The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men. J Clin Endocrinol Metab 86:2869-2874
19. Remes T, Vaisanen SB, Mahonen A, Huuskonen J, Kroger H, Jurvelin JS, Penttila IM, Rauramma R 2003 Aerobic exercise and bone mineral density in middle-aged Finnish men: a controlled randomized trial with reference to androgen receptor, aromatase, and estrogen receptor gene polymorphisms. Bone 32:412-420
20. Van Pottelbergh I, Goemaere S, Kaufman JM 2003 Bioavailable estradiol and aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age. J Clin Endocrinol Metab 88:3075-3081
21. Gennari L, Masi L, Merlotti D, Picariello L, Falchetti A, Tanini A, Mavilia C, Del Monte F, Gonnelli S, Lucani B, Gennari C 2004 A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. J Clin Endocrinol Metab 89:2803-2810
22. Khosla S, Melton III LJ, Atkinson EJ, O'Fallon WM 2001 Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 86:3555-3561
23. Khosla S, Melton III LJ, Riggs BL 2002 Estrogen and the male skeleton. J Clin Endocrinol Metab 87:1443-1450
24. Gennari L, Merlotti D, Martini G, Gonnelli S, Franci B, Campagna S, Lucani B, Dal Canto N, Valenti R, Gennari C, Nuti R 2003 Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J Clin Endocrinol Metab 88:5327-5333
25. Doran PM, Riggs BL, Atkinson EJ, Khosla S 2001 Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men. J Bone Miner Res 16:2118-2125
26. Uebelhart B, Herrmann F, Pavo I, Draper MW, Rizzoli R 2004 Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels. J Bone Miner Res 19:1518-1524
27. Duschek EJ, Gooren LJ, Netelenbos C 2004 Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men. Eur J Endocrinol 150:539-546
28. Orwoll E, Lambert LC, Marshall LM, Phipps K, Blank J, Barrett-Connor E, Cauley J, Ensrud K, Cummings S, for the Osteoporotic Fractures in Men Study Group 2006 Testosterone and estradiol among older men. J Clin Endocrinol Metab 91:1336-1344
29. Orwoll E, Blank RB, Barrett-Connor E, Cauley J, Cummings S, Ensrud K, Lewis C, Cawthon PM, Marcus R, Marshall LM, McGowan J, Phipps K, Sherman S, Stefanick ML, Stone K 2005 Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study-a large observational study of the determinants of fracture in older men. Contemp Clin Trials 26:569-585
30. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM Ensrud KE, Cauley J, Black D, Vogt TM 1995 Risk factors for hip fracture in white women. Study of osteoporotic fractures research group. N Engl J Med 332:767-773
31. Taylor BC, Schreiner PJ, Stone KL, Fink HA, Cummings SR, Nevitt MD, Bowman PJ, Ensrud KE 2004 Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures. J Am Geriatr Soc 52:1479-1486
32. Ferrini RL, Barrett-Connor E 1998 Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 147:750-754
33. de Ronde W, van der Schouw YT, Muller M, Grobbee DE, Gooren LJG, Pols HAP, de Jong FH 2005 Associations of sex hormone binding globulin with non-SHBG bound levels of testosterone and estradiol in independently living men. J Clin Endocrinol Metab 90:157-162
34. Burke CW, Anderson DC 1972 Sex-hormone binding globulin is an oestrogen amplifier. Nature 240:38-40
35. Simpson EV, Davis SR 2001 Aromatase and the regulation of estrogen biosynthesis-some new perspectives. Endocrinology 142:4589-4594
36. Simpson ER 2004 Models of aromatase insufficiency. Semin Reprod Med 22:25-30
37. Taieb J, Benattar C, Birr AS, Lindenbaum A 2002 Limitations of steroid determination by direct immunoassay. Clin Chem 48:583-585
38. Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, Neubauer G, Klibanski A 2004 Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 89:525-533
39. Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, Clyne CD, Davis S, Simpson ER, Carani C 2004 Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate and estradiol treatment. J Clin Endocrinol Metab 89:61-70